10-Q: Universal Display Q3 Revenue Dips Amid Royalty Adjustments

Universal Display Corporation reported a decline in third-quarter revenue and net income, primarily impacted by lower royalty and license fees and an out-of-period adjustment, despite growth in contract research services.

Summary

• Total revenue for the three months ended September 30, 2025, decreased by 14% to $139.6 million, compared to $161.6 million in the prior year period.
• Net income for the third quarter fell by 34% to $44.0 million, down from $66.9 million in the same period last year.
• Diluted EPS for the quarter was $0.92, a decrease from $1.40 in the third quarter of 2024.
• Royalty and license fees decreased by 29% to $53.3 million, including a $9.5 million reduction due to an out-of-period adjustment for an error originating in Q3 2023.
• Material sales saw a slight decrease of 1% to $82.6 million, with green emitter sales up 4% to $64.6 million, while red emitter sales declined by 12% to $16.8 million.
• Contract research services revenue increased by 1% to $3.7 million for the quarter, and by 63% to $17.7 million for the nine months ended September 30, 2025.
• For the nine months ended September 30, 2025, total revenue was $477.7 million, a 2% decrease from $485.4 million in the prior year, and net income was $175.7 million, a slight decrease from $176.1 million.
• Cash and cash equivalents increased to $121.6 million as of September 30, 2025, from $99.0 million at December 31, 2024, with total liquidity (cash, cash equivalents, and investments) reaching $1.0 billion.
• The company declared a cash dividend of $0.45 per common share for the third quarter, an increase from $0.40 in the prior year.
• Restructuring costs of $602,000 were recorded for the nine months ended September 30, 2025, related to the closure of the OVJP Corp facility in California and relocation of operations.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to significant declines in Q3 revenue and net income, primarily driven by lower royalty and license fees and an accounting adjustment. While year-to-date figures are more stable and contract research services show strong growth, the core OLED material and licensing business faced headwinds in the recent quarter. Strong liquidity and strategic investments provide some offset, but the immediate financial performance is a concern.

Positives

• Contract research services revenue increased significantly by 63% for the nine months ended September 30, 2025, reaching $17.7 million, indicating strong demand for Adesis's specialty manufacturing services.
• Green emitter sales volume increased by 4% for the three months ended September 30, 2025, demonstrating continued demand for a key product category.
• The company maintains a strong liquidity position with cash, cash equivalents, and investments totaling $1.0 billion as of September 30, 2025, up from $928.2 million at December 31, 2024.
• Cash dividends declared per common share increased to $0.45 for the quarter, reflecting confidence in future cash flows and commitment to shareholder returns.
• Strategic investments continue with the ongoing expansion of the Shannon, Ireland manufacturing facility, expected to double production capacity for phosphorescent emitters.
• A new patent acquisition agreement with Merck Electronics KGaA for $50.0 million is expected to close in January 2026, further strengthening the company's intellectual property portfolio.
• The company's effective income tax rate for the three months ended September 30, 2025, was 18.7%, lower than the statutory rate, due to benefits from foreign jurisdictions and R&D credits.

Negatives

• Total revenue for the three months ended September 30, 2025, decreased by 14% year-over-year, primarily driven by a 29% decline in royalty and license fees.
• Net income for the third quarter decreased by 34% to $44.0 million, and diluted EPS fell to $0.92 from $1.40 in the prior year.
• Royalty and license fees were negatively impacted by a $9.5 million out-of-period adjustment to correct an error from Q3 2023, and changes in customer mix.
• Red emitter sales volumes decreased by 12% for the three months ended September 30, 2025.
• Gross margin as a percentage of revenue decreased to 75% for the quarter, down from 78% in the prior year period.
• Operating income for the quarter decreased by 36% to $43.1 million.
• Cash provided by operating activities for the nine months ended September 30, 2025, decreased to $179.7 million from $219.0 million in the prior year period.
• The cumulative catch-up adjustment to revenue from changes in estimates of transaction price was lower ($3.9 million) for the nine months ended September 30, 2025, compared to the prior year ($6.1 million), indicating decreased anticipated demand by some customers.

Risks

• Fluctuations in annual and quarterly results of operations due to uncertainty regarding the timing, cost, and volume of OLED material sales.
• Uncertainty in the timing of receipt of license fees and royalties, as well as fees for future technology development and evaluation.
• Variability in the timing and magnitude of expenditures incurred in connection with ongoing research and development and patent-related activities.
• Uncertainty regarding the timing and financial consequences of forming new business relationships and alliances.
• Customer concentration risk, with Major Customer A accounting for 54% of Q3 2025 revenue and Major Customer B for 25% of Q3 2025 revenue.
• Geographic concentration risk, as approximately 97% of consolidated revenue for the three months ended September 30, 2025, was derived from outside North America, primarily South Korea and China.
• Supplier concentration risk, with substantially all chemical materials purchased from one supplier (PPG Industries, Inc.).
• Foreign exchange risk due to fluctuations in the Korean Won to U.S. Dollar exchange rate, impacting a significant Korean Won-denominated withholding tax receivable.
• Patent-related challenges and oppositions in various jurisdictions, which could lead to affirmation, denial, or modification of patent claims.
• The ultimate realization of deferred tax assets is dependent on the company's ability to generate future taxable income, and there is a valuation allowance for New Jersey research and development credits.

Future Outlook

The company anticipates fluctuations in annual and quarterly results due to uncertainties in the timing, cost, and volume of OLED material sales, receipt of license fees and royalties, R&D expenditures, and new business relationships. It expects to have sufficient cash, cash equivalents, and short-term investments to meet obligations for at least the next twelve months, based on internal forecasts. The company continues to evaluate the full impact of recent U.S. tax law changes (H.R. 1) and new accounting standards (ASU 2023-09, ASU 2025-05, ASU 2024-03). The Patent Sale Agreement with Merck Electronics KGaA for $50.0 million is expected to close in January 2026. The company's OVJP operations are relocating to Singapore and New Jersey, with a focus on assessing additional market opportunities beyond large-area displays, particularly in IT capacity demand.

Management Comments

• Management believes that OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost.
• Management believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor.
• Management believes that its technology leadership, intellectual property position, and more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable the company to continue to share in the revenues from OLED displays and lighting products as they continue to gain wider adoption.
• Management has evaluated the impacts of the out-of-period error (reducing royalty and license fees by $9.5 million for Q3 2025) and concluded that the error was not material to the Consolidated Financial Statements for any interim or annual period prior to the three months ended September 30, 2025, and is not expected to be material to the full year ending December 31, 2025.
• Management believes that opposition proceedings are frequently commenced in the ordinary course of business by third parties who may believe that one or more claims in a patent do not comply with the technical or legal requirements of the specific jurisdiction in which the patent was issued.
• Management views patent opposition proceedings as reflective of its goal of obtaining the broadest legally permissible patent coverage permitted in each jurisdiction.
• Management believes that as OLED technology becomes more established and its patent portfolio increases in size, so will the number of these proceedings.
• Management has been advised by a prominent Korean law firm that there is still a more likely-than-not chance of success in the Korean withholding tax dispute, as the manufacturing and sales process occurs within and without the Republic of Korea.
• Management anticipates having sufficient cash, cash equivalents, and short-term investments to meet obligations for at least the next twelve months.

Industry Context

The OLED market continues to capture a growing share across various applications, including mobile phones, televisions, monitors, wearables, tablets, notebooks, personal computers, AR/VR, and automotive. Universal Display Corporation, as a leader in OLED technologies and materials, is positioned to benefit from this expansion through its proprietary materials and licensing agreements with major display manufacturers like Samsung Display, LG Display, BOE, CSOT, Visionox, and Tianma. The company's strategic shift in OVJP operations to focus on IT capacity demand reflects an adaptation to evolving industry priorities. The ongoing expansion of its Ireland manufacturing facility underscores a commitment to meeting anticipated future demand and diversifying its supply chain, aligning with broader industry trends towards robust and geographically diverse production capabilities.

Comparison to Industry Standards

• The company's gross margin of 75% for Q3 2025, while a decrease from 78% in Q3 2024, remains robust and generally indicative of a strong intellectual property and proprietary materials business model, often exceeding typical manufacturing industry averages.
• The 63% increase in contract research services revenue for the nine months ended September 30, 2025, through its Adesis subsidiary, suggests strong performance in the contract development and manufacturing organization (CDMO) sector, potentially outperforming some specialized chemical synthesis providers.
• The company's substantial cash and investment position of $1.0 billion provides a strong financial buffer and capacity for strategic investments, comparable to well-capitalized technology leaders in the materials science space, enabling continued R&D and patent acquisitions.
• The ongoing patent acquisition strategy, exemplified by the $50.0 million agreement with Merck Electronics KGaA, is a common practice among technology leaders like Merck KGaA and BASF SE (from whom Universal Display previously acquired IP) to consolidate intellectual property and maintain competitive advantage in rapidly evolving fields like OLEDs.

Corporate Governance

Legal Proceedings

• The company is involved in patent-related challenges and oppositions in various jurisdictions, which are considered ordinary course of business and do not provide for monetary damages.
• The company is appealing a formal rejection from the Korean National Tax Service (KNTS) regarding a tax refund request for Korean withholding tax, with a petition filed to the District Court.
• The Korean Supreme Court issued a decision on September 18, 2025, changing its position on the taxation of royalties for patents not registered in Korea, which may impact the ongoing tax dispute.
• The company is currently under audits by the IRS for tax year 2023 and the state of California for tax years 2021 and 2022, both in the information-collecting stage.

Related Party Transactions

• The company has an Amended and Restated OLED Materials Supply and Service Agreement with PPG Industries, Inc. (PPG), under which PPG assists in developing and supplying OLED materials. The company compensates PPG on a cost-plus basis, with some services payable in cash and up to 50% of remaining services payable in cash or common stock at the company's discretion. No shares have been issued to PPG since the inception of the contract.
• The company has long-standing research agreements with academic institutions, including Princeton University and the University of Southern California (USC), involving royalty payments and research and development expenses.

Stakeholder Impact

• **Shareholders**: Experienced a decrease in net income and diluted EPS for the quarter, but received an increased cash dividend. The authorized share repurchase program could provide future value. The Korean tax dispute outcome could significantly impact future earnings.
• **Employees**: Stock-based compensation and ESPP activity continue, contributing to overall compensation. The closure of the OVJP Corp facility in California involved restructuring costs, indicating potential impact on employees at that location, while operations are relocating.
• **Customers**: Continued supply of OLED materials and licensing of technology under long-term agreements with major display manufacturers. Changes in anticipated demand by some customers led to adjustments in revenue estimates.
• **Suppliers**: The company maintains a concentration risk with substantially all chemical materials purchased from one supplier (PPG), indicating a critical relationship.
• **Creditors**: The company's strong liquidity position and working capital increase suggest a healthy financial standing, favorable for creditors.

Next Steps

• Continue to evaluate the full impact of the U.S. enacted H.R. 1 tax bill as additional guidance becomes available.
• Continue to evaluate the potential impact of new accounting standards ASU 2023-09, ASU 2025-05, and ASU 2024-03 on financial statements and disclosures.
• Proceed with the closing of the Patent Sale Agreement with Merck Electronics KGaA, expected in January 2026.
• Attend the next court hearing in November 2025 for the Korean withholding tax dispute.
• Continue to expand the manufacturing facility in Shannon, Ireland, to double production capacity and diversify the manufacturing base.
• Relocate OVJP operations to the newly formed Singapore subsidiary (UVJC) and the New Jersey Tech and Innovation Center.
• UVJC subsidiary plans to assess additional market opportunities for OVJP technology, particularly in the context of growing IT capacity demand.
• Management will continue to monitor the effectiveness of disclosure controls and procedures and internal control over financial reporting.

Key Dates

Recommendation

The company's Q3 2025 results show a notable decline in revenue and net income, primarily due to lower royalty and license fees and an out-of-period accounting adjustment. While year-to-date performance is more stable, and contract research services are growing strongly, the core OLED material and licensing business faces near-term headwinds. The company maintains a robust balance sheet with significant cash and investments, has increased its dividend, and is making strategic long-term investments in manufacturing capacity and patent acquisitions. However, the uncertainty surrounding the Korean tax dispute and the recent decline in key revenue streams warrant a cautious approach. Investors should hold, monitoring for stabilization in royalty and material sales, progress on the Korean tax case, and the impact of strategic investments on future growth.

Keywords

OLED, Organic Light Emitting Diode, Display Technology, Phosphorescent Emitters, Material Sales, Royalty Fees, License Agreements, Contract Research Services, Adesis, OVJP, Patent Portfolio, Financial Results, SEC Filing, Quarterly Report, Universal Display Corporation